Find uplifting stories about heroes, innovations, and solutions
166 results for "fda"
A quick, personalized brain stimulation therapy is now available in Arkansas for people whose depression hasn't responded to medication or counseling. The FDA-approved SAINT system at UAMS takes just five days and helps restore normal brain function.
President Trump signed an executive order to speed up research and potential FDA approval of psychedelic therapies for veterans suffering from PTSD, depression, and addiction. While the move brings hope to those who've exhausted traditional treatments, experts emphasize these therapies still need rigorous testing in controlled settings.
President Trump signed an executive order directing the FDA to expedite review of psychedelic drugs showing promise for veterans suffering from PTSD, depression, and traumatic brain injuries. One treatment already shows an 80-90% reduction in symptoms within one month.
President Trump signed an executive order to speed FDA review of psychedelic treatments showing 80-90% reduction in PTSD symptoms among veterans. The breakthrough therapy could help over 6,000 veterans who die by suicide each year.
SGMC Health is now providing FDA-approved infusion therapy that can slow early Alzheimer's progression, giving South Georgia families new hope. This marks one of the first treatments that targets the disease itself rather than just managing symptoms.
A new pill for pancreatic cancer helped patients live nearly twice as long as standard chemotherapy in a groundbreaking study. The experimental drug could bring hope to one of the deadliest cancers within months.
A 72-year-old Air Force veteran went from debilitating hand tremors to asking "what tremor?" immediately after a groundbreaking ultrasound treatment. The FDA recently approved this incision-free procedure that targets Parkinson's symptoms with pinpoint precision.
Four promising new treatments could reach patients this spring, offering fresh hope for people battling hard-to-treat conditions. From the first-ever medication for a chronic liver infection to an at-home Alzheimer's treatment, these therapies represent real progress for patients who've been waiting.
A revolutionary cable-free medical imaging system developed through French collaboration just received FDA clearance. The five-year partnership between GE HealthCare, a research institute, and a small manufacturer is transforming hospital procedures worldwide.
When teenagers with bone cancer spoke directly to the FDA about their treatment experiences, regulators listened and changed how trials work. Now patient voices are becoming the most powerful tool in medical research.
After 20 years without new treatments, the FDA approved Avlayah, the first therapy designed to treat both physical and neurological symptoms of Hunter syndrome. The breakthrough offers hope to families battling this rare disease that causes progressive organ damage and early death.
Scientists discovered that inflammation, not just cholesterol, may cause up to a quarter of heart disease deaths. An affordable drug already used for gout just got FDA approval to prevent heart attacks by calming this hidden threat.
A Baltimore medical company just received FDA clearance for a device that makes minimally invasive heart procedures safer and easier. The breakthrough tool completed its first human trials with 100% success and zero complications.
A breakthrough pill for pancreatic cancer almost doubled survival time and cut death risk by 60% in a major trial. Revolution Medicines plans to seek fast-track FDA approval for patients who desperately need new treatment options.
Rebecca King Crews spent years seeking answers before her Parkinson's diagnosis at age 50, but a breakthrough FDA-approved treatment is now helping manage her symptoms without surgery. Her story shines light on early-onset Parkinson's and a promising new therapy option.
%3Amax_bytes(150000)%3Astrip_icc()%3Afocal(999x0%3A1001x2)%2Fterry-crews-rebecca-crews-PEOPLE-040326-4-17748130789f487d81b448f2e96b3b23.jpg)
Rebecca Crews underwent a groundbreaking five-hour procedure that uses focused ultrasound to reduce debilitating Parkinson's tremors without a single incision. Within hours of treatment, she could lift her leg and write legibly again after years of struggling with basic tasks.
Researchers at the University of Michigan have discovered what causes a rare condition that makes walking so painful patients crawl instead. An FDA-approved cream has already shown promise in early trials.
The FDA just approved testing of a revolutionary therapy that could cure lupus, rheumatoid arthritis, and other autoimmune diseases without harsh chemotherapy. The breakthrough could help 15 million Americans escape lifelong medications.
A secret FDA-approved drug called "compound X" helped mice with Parkinson's symptoms walk and balance normally by clearing toxic brain proteins. Human trials could start within a year, offering hope for 10 million people worldwide living with the disease.
Researchers screened 774 FDA-approved drugs using zebrafish to create a precision medicine map for autism, identifying levocarnitine as a compound that reverses brain deficits caused by specific genetic mutations. The breakthrough could help doctors match treatments to individual patients based on their unique genetic profile.
Showing 20 of 166